abstract |
The present invention relates to monitoring and diagnosing cancer, particularly monitoring cancer progression or development, monitoring cancer response to therapy, diagnosing cancer, performing cancer prognosis, Methods are provided for obtaining information related to predicting the likelihood of responding to treatment and stratifying subjects with cancer. The method includes determining a ratio of circulating CCL17 to circulating CCL22 in a sample from the subject. [Selection] Figure 16 |